Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.57 |
| ▸ | HNF4A | P41235 | 4/20 | 0.56 |
| ▸ | ACMSD | Q8TDX5 | 2/20 | 0.56 |
| ▸ | DHFR | P00374 | 1/20 | 0.56 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.56 |
| ▸ | CDC25A | P30304 | 1/20 | 0.56 |
| ▸ | CDC25B | P30305 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29417548 | 1.00 | TDP1 (0.59) | TDP1L3MBTL1KDM4EPOLBATM | |
| SCHEMBL11790065 | 0.92 | TDP1 (0.62) | TDP1L3MBTL1KDM4EPOLBHNF4A | |
| SCHEMBL21887391 | 0.89 | TDP1 (0.76) | TDP1L3MBTL1KDM4EPOLBSRD5A2 | |
| SCHEMBL9619552 | 0.85 | LIG1 (0.65) | TDP1L3MBTL1KDM4EPOLBATM | |
| SCHEMBL9472920 | 0.85 | KDM4E (0.70) | L3MBTL1KDM4EPOLBSRD5A2HNF4A | |
| SCHEMBL1537110 | 0.85 | KMT2A (0.59) | TDP1L3MBTL1KDM4EPOLBATM | |
| SCHEMBL1295856 | 0.84 | CDC25B (0.78) | TDP1L3MBTL1KDM4EPOLBATM | |
| Benzophenone SCHEMBL8946163 | 0.84 | CDC25B (0.78) | TDP1L3MBTL1KDM4EPOLBATM | |
| SCHEMBL11157010 | 0.83 | LIG1 (0.67) | TDP1L3MBTL1KDM4EATMCDC25A | |
| SCHEMBL142204 | 0.82 | L3MBTL1 (0.64) | TDP1L3MBTL1KDM4EPOLBATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1612 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144729-A1 | A CLEANSING COMPOSITION | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| EP-4611719-A1 | A CLEANSING COMPOSITION | L'OREAL (FR) | 2025-09-10 | — | — | EP | claimed |
| CN-120076784-A | Cleaning composition | 莱雅公司 | 2025-05-30 | — | — | CN | claimed |
| WO-2024092386-A1 | A CLEANSING COMPOSITION | L'OREAL (FR) | 2024-05-10 | — | — | WO | claimed |
| CN-107213027-B | Cosmetic composition with skin repairing and moistening functions and preparation method thereof | 广州澳希亚实业有限公司 | 2020-06-26 | — | — | CN | claimed |
| CN-108478497-B | Deep moisturizing composition and application thereof in skin care products | 广州澳希亚实业有限公司 | 2020-06-23 | — | — | CN | claimed |
| CN-108653176-A | A kind of crease-resistant remediation composition and its application in cosmetics | 广州澳希亚实业有限公司 | 2018-10-16 | — | — | CN | claimed |
| CN-108478497-A | A kind of deep water supplement moisture-keeping composition and its application in skin care item | 广州澳希亚实业有限公司 | 2018-09-04 | — | — | CN | claimed |
| CN-107213027-A | Cosmetic composition with skin repairing and moistening functions and preparation method thereof | 广州澳希亚实业有限公司 | 2017-09-29 | — | — | CN | claimed |
| US-8974804-B2 | Composition in the form of an oil-in-water emulsion and uses thereof | L'OREAL (FR) | 2015-03-10 | — | — | US | claimed |
| WO-2008083975-A1 | LIGHT-STABILIZED COMPOSITION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | claimed |
| WO-2008067928-A1 | UV ABSORBING COMPOSITIONS CONTAINING A PYRROLYLTRIAZINE | ISDIN S.A. (ES) | 2008-06-12 | — | — | WO | claimed |
| EP-1555984-B1 | PROCESS FOR DISSOLVING LIPOPHILIC COMPOUNDS, AND COSMETIC COMPOSITION. | OREAL (FR) | 2008-03-12 | — | — | EP | claimed |
| US-20070253989-A1 | Modified Powder and Cosmetic Composition Using the Same | SHISEIDO CO., LTD. (JP) | 2007-11-01 | — | — | US | claimed |
| EP-1415645-B1 | Composition in the form of an oil-in-water emulsion and its cosmetic uses | OREAL (FR) | 2007-10-03 | — | — | EP | claimed |
| US-20060024337-A1 | Process for dissolving lipophilic compounds in aqueous solution with amphiphilic block copolymers, and cosmetic composition | L'OREAL (FR) | 2006-02-02 | — | — | US | claimed |
| EP-1555984-A2 | PROCESS FOR DISSOLVING LIPOPHILIC COMPOUNDS, AND COSMETIC COMPOSITION. | L'OREAL (FR) | 2005-07-27 | — | — | EP | claimed |
| US-20040166128-A1 | Composition in the form of an oil-in-water emulsion and uses thereof | L'OREAL (FR) | 2004-08-26 | — | — | US | claimed |
| WO-2004035013-A2 | PROCESS FOR DISSOLVING LIPOPHILIC COMPOUNDS, AND COSMETIC COMPOSITION | L'OREAL (FR) | 2004-04-29 | — | — | WO | claimed |
| US-6365139-B2 | Cosmetic stick | AVON PRODUCTS, INC. | 2002-04-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040166128-A1 | Composition in the form of an oil-in-water emulsion and uses thereof | PLOD3, CUTA, LOXL1 | TDP1 2034/4885L3MBTL1 2206/4885KDM4E 4439/4885 |
| US-20060024337-A1 | Process for dissolving lipophilic compounds in aqueous solution with amphiphilic block copolymers, and cosmetic composition | LIPA, ABCB4, MGLL | TDP1 1848/4885L3MBTL1 2273/4885KDM4E 4429/4885 |
| US-20260144729-A1 | A CLEANSING COMPOSITION | SMURF1, CUTA, S100B | TDP1 2354/4885L3MBTL1 2799/4885KDM4E 2345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.